R&D Center

Contrast agent

Pipeline	Indication	Research	Non-clinical	Clinical	Permission
Fatiodol	Lymph, Salivary gland contrast, Liver cancer TACE1

Medical Device

Pipeline	Indication	Research	Non-clinical	Clinical	Permission
Arthro-seal	Substitute for arthroscopic synovial fluid
MRI Pad	MRI noise reduction pad
Hemostatic product for absorbent body contents	Haemostasis in vascular incision site

API

Pipeline	Indication	2020	2021	2022	2023	2024	2025
MRI contrast agent	Liver MRI contrast agent, lesion ascertainment and characterization	development	pilot production	approval	launch	export
CT contrast agent	Spinal cord, blood vessels, intravenous urography, 제강조영, CT contrast enhancement and etc	development	pilot production	approval	launch	export
CT contrast agent	Cardiovascular, cerebrovascular, peripheral artery, abdominal vascular, venous, spinal cord, joint, CT contrast enhancement and etc	development		pilot production	approval	launch	export
CT contrast agent	Intravenous urography, CT contrast enhancement, artery, cardiovascular, joint, hysteromucography			development	pilot production	approval	launch